ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
77,95
1,51
(1,98%)
Geschlossen 06 Juni 5:30PM

Sanofi (SAN) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
77,95
( 1,98% )
Gebot
77,50
Fragen
78,00
Volumen
2.189.664
76,71 Tagesbereich 78,43
71,73 52-Wochen-Bereich 91,15
Marktkapitalisierung
Handelsende
76,44
Handelsbeginn
76,80
Letzte Trade
54
@
77.95
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
2.516.708 €
Ausgegebene Aktien
1.200.220.109
Dividendenrendite (LTM)
(5,64%)
Kurs-Gewinn-Verhältnis
18,99
Gewinn pro Aktie (EPS)
6,2
Erlöse (LTM)
47,35B
Nettogewinn (LTM)
7,56B

Über Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respi... Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine’s AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV’574, for treatment of ulcerative colitis and Crohn’s disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Paris, France
Gegründet
1994
Sanofi is listed in the Healthcare sector of the Euronext with ticker SAN. The last closing price for Sanofi was 76,44 €. Over the last year, Sanofi shares have traded in a share price range of 71,73 € to 91,15 €.

Sanofi currently has 1.200.220.109 shares in issue. The market capitalisation of Sanofi is 93,56 € billion. Sanofi has a price to earnings ratio (PE ratio) of 18.99.

SAN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.271.6562336984976.6878.4372.71286027074.84896275DE
44.626.3002863766573.3378.4371.73221576575.00489326DE
122.092.7550751384175.8684.0471.73251844377.86269747DE
26-6.35-7.5326215895684.385.8671.73241983878.96252345DE
52-9.16-10.51544024887.1191.1571.73208869781.25461447DE
156-17.25-18.119747899295.2110.8871.73174220889.68627206DE
260-7.96-9.2655104178885.91110.8871.73183577290.22671699DE

SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 77,95 €
How many Sanofi shares are in issue?
Sanofi has 1.200.220.109 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 93,56B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 71,73 € to 91,15 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 18,99
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 1,91
What is the registered address of Sanofi?
The registered address for Sanofi is 46, avenue de la Grande ArmEe, Paris, Ile-de-France, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the Pharmaceuticals sector

SAN Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen